Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Novonesis (GB:0Q4U)
LSE:0Q4U
Holding GB:0Q4U?
Track your performance easily
0Q4U Stock Chart & Stats
Day’s Rangekr0 - kr0
52-Week Rangekr335.00 - kr547.40
Previous Closekr416.25
Volume323.79K
Average Volume (3M)135.28K
Market Cap
kr197.00B
Enterprise Valuekr196.68B
Total Cash (Recent Filing)kr1.12B
Total Debt (Recent Filing)kr411.00M
Price to Earnings (P/E)38.4
Beta0.80
Next Earnings
Feb 26, 2025EPS Estimate
kr4.89Last Dividend Ex-Date
Aug 30, 2024Dividend Yield0.95%
Share Statistics
EPS (TTM)10.91
Shares OutstandingN/A
10 Day Avg. Volume22,677
30 Day Avg. Volume135,283
Standard Deviation0.07
R-Squared0.07
Alpha0.00781
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)5.64
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
kr493.13Price Target Upside18.47% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering8
Novonesis News
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
6.27% Mutual Funds
0.02% Other Institutional Investors
86.13% Public Companies and
Individual Investors
0Q4U FAQ
What was Novonesis’s price range in the past 12 months?
Novonesis lowest share price was kr335.00 and its highest was kr547.40 in the past 12 months.
What is Novonesis’s market cap?
Currently, no data Available
When is Novonesis’s upcoming earnings report date?
Novonesis’s upcoming earnings report date is Feb 26, 2025 which is in 109 days.
How were Novonesis’s earnings last quarter?
Currently, no data Available
Is Novonesis overvalued?
According to Wall Street analysts Novonesis’s price is currently Undervalued.
Does Novonesis pay dividends?
Novonesis pays a Annually dividend of kr2 which represents an annual dividend yield of 0.95%. See more information on Novonesis dividends here
What is Novonesis’s EPS estimate?
Novonesis’s EPS estimate is kr4.89.
How many shares outstanding does Novonesis have?
Novonesis has 414,555,050 shares outstanding.
What happened to Novonesis’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Novonesis?
Currently, no hedge funds are holding shares in GB:0Q4U
---
Novonesis Stock Smart Score
Company Description
Novonesis
Novozymes is the world leader in industrial enzymes. In recent years, the company has expanded into micro-organisms, primarily for agricultural markets. The firm supplies five major industry groups: household care, food and beverages, bioenergy, agriculture and feed, and technical and pharma. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark.
---
0Q4U Revenue Breakdown
28.53% Household Care
24.83% Bioenergy
22.07% Food, Beverages & Human Health
12.82% Grain & Tech Processing
11.75% Agriculture & Animal Health
---
0Q4U Stock 12 Month Forecast
Average Price Target
kr493.13
▲(18.47% Upside)
Technical Analysis
Best Analysts Covering 0Q4U
1 Year
1 Year Success Rate
7/15 ratings generated profit
1 Year Average Return
-2.93%
reiterated a buy rating 2 months ago
Copying Sebastian Bray's trades and holding each position for 1 Year would result in 46.67% of your transactions generating a profit, with an average return of -2.93% per trade.
---